Wednesday, August 20 2014 5:43 AM EDT2014-08-20 09:43:48 GMT
A young girl says she was standing up for her religious beliefs in the classroom after breaking a class rule.More >>
A young girl, who claims she was standing up for her religious beliefs in the classroom, was suspended after breaking a class rule of saying "bless you" after a classmate sneezed. More >>
Vancouver, BC / ACCESSWIRE / April 30, 2014 / Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTC PINK: ATTBF) (CSE: ATT), The Company wishes to announce that pursuant to two consulting agreements with arm’s length parties, it has issued an aggregate of 33,669 common shares at a deemed price of CAD 0.99/share as consideration for services provided to the Company.
The Company is also pleased to announce that we will be hosting a corporate presentation at The Terminal City Club Metropolitan Room, 837 West Hastings Street Vancouver, between the hours of 2 and 6 pm PST on May 1, 2014. Special guest speakers Georges Laraque and Rene Babi New Products Pre- Release Announcement. Dr. Paula Brown, MMPR Importance of Safety and Standards will be presenting along with Company CEO Mike Withrow. If you are interested in attending please RSVP to Denby Greenslade, Denby.Greenslade@Abattis.com as soon as possible as seating is limited.
About Abattis Bioceuticals Corp.
Abattis isaspecialtybiotechnology company withcapabilitiesthroughitswholly owned subsidiariesofcultivating,licensingandmarketingproprietary ingredients,bio-similar compounds,patented equipmentandconsultingservicestomedicinal marketsinNorth America. Thecompanyispositionedtocapitalizeonthefast growingtrendtoward marijuanalegalizationintheUnitedStatesandformedicinal useinCanada and internationaljurisdictionsby supplyingandpartneringwithcompaniestoemployits verticalcultivationsystems, extraction equipment/technology,andstrategicmarketing support tolicensedgrowers. Thecompanyalso has an extensive pipelineof high-quality products andIntellectualProperty fortherapidly expandingbotanicaldrug market.We follow strictStandardOperatingProtocolsandadheretotheLaw‘sofCanadaand ForeignJurisdictions. For more information, visit theCompany‘swebsite at www.abattis.com.
NEITHER THE CANADIAN SECURITIESEXCHANGENORITSREGULATIONSSERVICES PROVIDER HAVEREVIEWED OR ACCEPTRESPONSIBILITYFOR THEADEQUACY OR ACCURACYOFTHISRELEASE.
FORWARD LOOKING INFORMATION
Thispressrelease contains forward-looking statements.Theuseofanyofthewords“anticipate“, “continue“, “estimate“, “expect“, “may“,“will“,“project“,“should“,“believe“and similarexpressionsareintended toidentify forward-lookingstatements. Althoughthe Companybelievesthattheexpectationsandassumptionsonwhichtheforward-lookingstatementsarebasedarereasonable, undue reliance shouldnotbe placed on the forward-looking statementsbecause the Company can give no assurance thatthey will provetobecorrect.Sinceforward-lookingstatementsaddressfutureeventsandconditions,bytheirverynaturetheyinvolve inherentrisksanduncertainties.Thesestatementsspeakonlyasofthedateofthispressrelease.Actualresultscoulddiffer materiallyfromthose currentlyanticipatedduetoanumberoffactorsandrisksvariousriskfactorsdiscussedintheCompany‘s Management‘sDiscussionandAnalysisundertheCompany‘sprofileonwww.sedar.com. WhiletheCompany mayelect to, it does notundertake toupdate this information atany particulartime.